CARA

Cara Therapeutics, Inc.

Healthcare

Set alert

Price alert · CARA

All alert types
5.32 0.00 0.00%
As of Apr 15, 2025
5.28 Day range 5.52

52-week range unavailable

YTD
-71.02%
1 year
-79.19%
Open
4.80
Prev close
5.32
Mkt cap
25.09M
Vol
236.84K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
5.28
High
5.52
Forward P/E
-0.59
Beta
0.68
Short ratio
2.20
Inst. own
28.16%
Dividend
0.00
Ex-div date
50-d avg
0.29152
200-d avg
0.46241
1y target
1.01

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CARA has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-9.74 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.5×
FY 2016: -159×FY 2017: -237×FY 2018: -227×FY 2019: -233×FY 2020: 3026×FY 2021: -252×FY 2022: -249×FY 2023: -12.2×FY 2024: -11.8×FY 2025: -6.5×
FY 2016 5y median -12.2× FY 2025
P/S 0.0×
FY 2016: 106073×FY 2017: 15092×FY 2018: 1247×FY 2019: 1244×FY 2020: 191×FY 2021: 966×FY 2022: 495×FY 2023: 69.1×FY 2024: 117×FY 2025: 0.0×
FY 2016 5y median 117× FY 2025
P/B 5653×
FY 2016: 180×FY 2017: 158×FY 2018: 126×FY 2019: 133×FY 2020: 104×FY 2021: 97.7×FY 2022: 131×FY 2023: 25.4×FY 2024: -182×FY 2025: 5653×
FY 2016 5y median 97.7× FY 2025
P/FCF -5039×
FY 2016: -190×FY 2017: -251×FY 2018: -751×FY 2019: -227×FY 2020: -4425×FY 2021: -370×FY 2022: -263×FY 2023: -15.3×FY 2024: -13.5×FY 2025: -5039×
FY 2016 5y median -263× FY 2025
EV/EBITDA 1246186×
FY 2016: -160×FY 2017: -233×FY 2018: -218×FY 2019: -222×FY 2020: 3255×FY 2021: -252×FY 2022: -246×FY 2023: -12.2×FY 2024: -12.8×FY 2025: 1246186×
FY 2016 5y median -12.8× FY 2025
EV/Sales 0.0×
FY 2016: 105932×FY 2017: 15082×FY 2018: 1246×FY 2019: 1244×FY 2020: 191×FY 2021: 965×FY 2022: 494×FY 2023: 68.7×FY 2024: 112×FY 2025: 0.0×
FY 2016 5y median 112× FY 2025
FCF Yield -0.0%
FY 2016: -0.5%FY 2017: -0.4%FY 2018: -0.1%FY 2019: -0.4%FY 2020: -0.0%FY 2021: -0.3%FY 2022: -0.4%FY 2023: -6.5%FY 2024: -7.4%FY 2025: -0.0%
FY 2016 5y median -0.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -57170.9%FY 2017: -5226.5%FY 2018: -460.8%FY 2019: -469.1%FY 2020: 20.7%FY 2021: 93.3%FY 2022: 82.6%FY 2023: 69.3%FY 2024: 91.3%FY 2025: 0.0%
FY 2016 5y median 82.6% FY 2025
Operating Margin 0.0%
FY 2016: -67907.0%FY 2017: -6529.6%FY 2018: -574.5%FY 2019: -561.6%FY 2020: 4.0%FY 2021: -386.8%FY 2022: -209.1%FY 2023: -579.4%FY 2024: -818.0%FY 2025: 0.0%
FY 2016 5y median -386.8% FY 2025
Net Margin 0.0%
FY 2016: -66604.7%FY 2017: -6380.4%FY 2018: -549.5%FY 2019: -534.9%FY 2020: 6.2%FY 2021: -383.0%FY 2022: -199.2%FY 2023: -565.2%FY 2024: -993.0%FY 2025: 0.0%
FY 2016 5y median -383.0% FY 2025
ROE -87.0%
FY 2016: -112.9%FY 2017: -67.0%FY 2018: -55.4%FY 2019: -57.0%FY 2020: 3.4%FY 2021: -38.8%FY 2022: -52.5%FY 2023: -207.6%FY 2024: 1542.9%FY 2025: -87.0%
FY 2016 5y median -52.5% FY 2025
ROIC -126.5%
FY 2016: -110.8%FY 2017: -67.0%FY 2018: -51.2%FY 2019: -58.0%FY 2020: 2.1%FY 2021: -38.5%FY 2022: -54.5%FY 2023: -121.2%FY 2024: -145.7%FY 2025: -126.5%
FY 2016 5y median -121.2% FY 2025
ROA -56.8%
FY 2016: -89.7%FY 2017: -59.9%FY 2018: -38.8%FY 2019: -45.7%FY 2020: 3.1%FY 2021: -35.7%FY 2022: -45.8%FY 2023: -94.2%FY 2024: -161.7%FY 2025: -56.8%
FY 2016 5y median -56.8% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -97.7%FY 2017: 959.3%FY 2018: 1378.5%FY 2019: 47.6%FY 2020: 579.3%FY 2021: -83.0%FY 2022: 81.8%FY 2023: -49.9%FY 2024: -66.0%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income 54.2%
FY 2016: -131.9%FY 2017: -1.9%FY 2018: -30.1%FY 2019: -44.3%FY 2020: 104.8%FY 2021: -1754.3%FY 2022: 1.7%FY 2023: -38.8%FY 2024: 51.9%FY 2025: 54.2%
FY 2016 FY 2025
EPS (diluted) -110.3%
FY 2016: -110.0%FY 2017: 11.4%FY 2018: -10.8%FY 2019: -20.9%FY 2020: 107.2%FY 2021: -1066.7%FY 2022: 10.9%FY 2023: -41.3%FY 2024: 29.2%FY 2025: -110.3%
FY 2016 FY 2025
Free Cash Flow 62.1%
FY 2016: -123.7%FY 2017: -14.1%FY 2018: 59.2%FY 2019: -388.3%FY 2020: 94.7%FY 2021: -930.3%FY 2022: -31.0%FY 2023: -19.9%FY 2024: 34.4%FY 2025: 62.1%
FY 2016 FY 2025

Financial Health

Current Ratio 2.9×
FY 2016: 5.3×FY 2017: 11.2×FY 2018: 4.2×FY 2019: 3.9×FY 2020: 10.6×FY 2021: 9.8×FY 2022: 7.2×FY 2023: 4.5×FY 2024: 11.0×FY 2025: 2.9×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 2.9×
FY 2016: 5.3×FY 2017: 11.2×FY 2018: 4.2×FY 2019: 3.9×FY 2020: 10.6×FY 2021: 9.7×FY 2022: 7.1×FY 2023: 4.4×FY 2024: 10.8×FY 2025: 2.9×
FY 2016 5y median 7.1× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.8×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -216×
FY 2016: 0.2×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.1×FY 2020: -2.9×FY 2021: 0.1×FY 2022: 0.7×FY 2023: 0.1×FY 2024: 0.6×FY 2025: -216×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -201×FY 2024: -6.9×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31